CPIC (2601 HK) Company Update
Key Highlights:
- VNB Growth Acceleration: CPIC witnessed a significant increase in its Variable Net Benefit (VNB) growth by 30.7% year-over-year (YoY) in the first quarter of 2024, surpassing peers like China Life and Ping An.
- Positive Net Profit Turnaround: CPIC's net profit to shareholders reached a positive figure of RMB11.8 billion in the first quarter of 2024, marking the first among listed Chinese insurers to achieve this milestone.
- Life Focus Shift: The company has re-focused on agency distribution channels, with a notable increase in FYRP/FYSP (+25.4%/+44.5% YoY), reversing the trend seen in the previous quarter.
- Channel Diversification: Bancassurance continues to face challenges but shows signs of improvement, with FYP declining by -21.8% YoY in the first quarter of 2024, compared to a -54.6% decline in the previous quarter.
- P&C Segment Performance: Premiums for the Property & Casualty (P&C) segment dropped by -0.4 percentage points to 98%, driven by growth in non-auto segments.
Financial Performance Overview:
- Profitability and NAV: Under International Financial Reporting Standards (IFRS) 9 and IFRS 17, CPIC's insurance revenue increased by 2.4% YoY, while insurance service expenses saw a slight increase of 2.7% YoY. Net investment results declined by 26.1% YoY due to reduced net interest income and investment income.
- Operating Profit: The operating profit before tax was down by 5.8% YoY, indicating a marginal decrease despite strong VNB growth.
- Net Asset Value: CPIC's net asset value per share increased by 3.3% YoY, highlighting the insurer's resilient financial position.
Valuation and Outlook:
CPIC's target price has been adjusted to HK$24.8, implying a forward price-to-book ratio of 0.84 times and a price-to-ev ratio of 0.40 times. This reflects expectations of continued efficiency gains from the Changhang Transformation initiative, despite a high base for growth in the second quarter of 2024 due to the strong performance in the first quarter. Analysts maintain a positive outlook on CPIC, recommending a buy based on its resilient profitability and potential for further growth.
